Dr
Bal
Matharu

Partner & Patent Attorney

Manchester Office

Chemistry

Telephone. +44(0) 161 247 4900
Mobile. +44(0) 782 791 7932
Email. [email protected]

Experience

Bal is an experienced patent attorney and has worked within the pharmaceutical field for over 20 years. He has a strong technical background and has held senior roles within both the R&D and IP functions of global pharmaceutical and drug delivery companies.

During his career he has built and defended patent portfolios protecting products at all stages of development, including a range of high-profile on-market medicines.

Bal has a first degree in Pharmacy and a PhD in drug delivery and started his career with AstraZeneca as a senior product development scientist. During his time in this role, he led several technical programs to develop and repurpose drug candidates and is an inventor on patents protecting one of AZ’s oncology medicines.

In 2006, Bal transitioned into the IP department of AZ and progressed to the role of senior patent attorney. He has managed global patent portfolios protecting key products and he has also led IP due diligence activities for licensing and late-stage acquisitions. During his last 3 years at AZ, Bal was seconded into the litigation group to defend patents protecting a CNS product in multiple jurisdictions across Europe, South America and Asia.

Bal has developed an in-depth knowledge of the strategic aspects of multi-jurisdictional pharmaceutical patent litigation and also regularly acts as lead counsel in European patent opposition and appeal proceedings.

Since joining HGF, Bal has used his patent expertise and understanding of drug discovery and development to help clients focus their IP activities and achieve their commercial objectives.

Qualifications

Patent Attorney

Chartered (UK)
Europe


BSC

BPharm, Pharmacy

PHD

Biopharmaceutics and Drug Delivery

Publications

Impact of AI Approaches on Patent Strategy in Healthcare

Conferences: 2022

September 22nd 2022

BioCap Conference 2022

Attended

Event details

Conferences: 2019

March 14th 2019

IP in Healthcare Conference 2019 - London & Manchester

Speaker

Event details

CSR

Visiting lecturer at King’s College London and contribute to drug development modules of MPharm Pharmacy degree course.

Mentoring trainee patent attorneys.

Previously lectured on JDD course for EQE qualifications.

Related News

From Theoretical Proposals to Commercial Reality: The Rise of Innovation and Patent Filings in Quantum Computing

The possibility of quantum computing was first seriously proposed in the early 1980s and is widely regarded as having enormous potential to deliver a step change in the complexity of …

Read article
Event - 3rd February 2023

The European Patent Office are running an inspiring collaborative art competition for children

To celebrate the 50th anniversary of the signing of the European Patent Convention, The European Patent Office (EPO) is running a collaborative art competition for primary schools on the topic …

Event details
Event - 8th-9th February 2023

5th Annual Microbiome & Probiotic Conference 2023

The 5th Annual MarketsandMarkets Next Gen Microbiome and Probiotics Conference will take place in San Diego on the 8th-9th of February. This conference will enable you to learn about microbial …

Event details
Event - 17th January 2023

CIPA Webinar: Enhancing Diversity in the Patent Profession How Can I Help

CIPA hosted a webinar to discuss ‘Enhancing diversity in the patent profession.’ Date Tuesday 17 January, 2023 Time 12.30pm – 1.30pm (GMT) Equity, diversity and inclusion has been in the …

Event details

LiDAR: A Significant Support Technology at CES

When visiting CES’ one thing that struck me was the number of companies demonstrating LiDAR technology. LiDAR has been around since the 1960s and was originally developed for aerospace use, …

Read article

Healthcare and Climate Change

Can we find a balance between intellectual property rights and public health needs when tackling the climate crisis? “The world faces a critical juncture. A health-centred, aligned response to the …

Read article

Navigating the CRISPR IP confusion

It is just over 10 years since the Science publication of Jinek et al. showed for the first time that DNA cleavage could be achieved in vitro with a Cas9 …

Read article

CRISPR Edited T cells win the TvT Battle

T-cells which have been modified using CRISPR base editing technology have been successfully used to treat T-cell acute lymphoblastic leukaemia for the first time {1}. A 13 year old patient …

Read article

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.